Literature DB >> 16142232

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.

Piyush B Gupta1, Charlotte Kuperwasser, Jean-Philippe Brunet, Sridhar Ramaswamy, Wen-Lin Kuo, Joe W Gray, Stephen P Naber, Robert A Weinberg.   

Abstract

The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142232      PMCID: PMC1694635          DOI: 10.1038/ng1634

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  42 in total

1.  A genetically tractable model of human glioma formation.

Authors:  J N Rich; C Guo; R E McLendon; D D Bigner; X F Wang; C M Counter
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

2.  Inhibition of neural crest migration in Xenopus using antisense slug RNA.

Authors:  T F Carl; C Dufton; J Hanken; M W Klymkowsky
Journal:  Dev Biol       Date:  1999-09-01       Impact factor: 3.582

3.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

4.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

5.  Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

Authors:  C Kuperwasser; G D Hurlbut; F S Kittrell; E S Dickinson; R Laucirica; D Medina; S P Naber; D J Jerry
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

7.  The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.

Authors:  J Bartkova; J Lukas; P Guldberg; J Alsner; A F Kirkin; J Zeuthen; J Bartek
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

8.  Benign "metastatic" cellular blue nevus.

Authors:  A Bortolani; D Barisoni; G Scomazzoni
Journal:  Ann Plast Surg       Date:  1994-10       Impact factor: 1.539

9.  Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel.

Authors:  D L Phillips; K G Benner; E B Keeffe; S T Traweek
Journal:  J Clin Gastroenterol       Date:  1987-10       Impact factor: 3.062

10.  Shaping of tumor and drug-resistant genomes by instability and selection.

Authors:  Antoine M Snijders; Jane Fridlyand; Dorus A Mans; Richard Segraves; Ajay N Jain; Daniel Pinkel; Donna G Albertson
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

View more
  207 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  From genes to drugs: targeted strategies for melanoma.

Authors:  Keith T Flaherty; F Stephen Hodi; David E Fisher
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

Review 3.  Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

Authors:  Tetyana V Bagnyukova; Ilya G Serebriiskii; Yan Zhou; Elizabeth A Hopper-Borge; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

4.  Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

Authors:  Ke-Jun Zhang; Bing-Yuan Zhang; Kun-Peng Zhang; Li-Min Tang; Shi-Song Liu; Dong-Ming Zhu; Dian-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

5.  Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential.

Authors:  Ke Yang; Jin Chen; Wei Jiang; Enyi Huang; Jing Cui; Stephanie H Kim; Ning Hu; Hong Liu; Wenwen Zhang; Ruidong Li; Xiang Chen; Yuhan Kong; Jiye Zhang; Jinhua Wang; Linyuan Wang; Jikun Shen; Hue H Luu; Rex C Haydon; Xiaohua Lian; Tian Yang; Tong-Chuan He
Journal:  J Invest Dermatol       Date:  2012-05-17       Impact factor: 8.551

6.  Genes and pathways downstream of telomerase in melanoma metastasis.

Authors:  Sepideh Bagheri; Mehdi Nosrati; Shang Li; Sylvia Fong; Sima Torabian; Javier Rangel; Dan H Moore; Scot Federman; Rebecca R Laposa; Frederick L Baehner; Richard W Sagebiel; James E Cleaver; Christopher Haqq; Robert J Debs; Elizabeth H Blackburn; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

7.  Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r.

Authors:  Elodie Le Pape; Thierry Passeron; Alessio Giubellino; Julio C Valencia; Rainer Wolber; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

8.  Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance.

Authors:  Anna V Roschke; Oleg K Glebov; Samir Lababidi; Kristen S Gehlhaus; John N Weinstein; Ilan R Kirsch
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Authors:  Kang Ho Kim; Ho Jun Seol; Eun Hee Kim; Jinguen Rheey; Hyun Jin Jin; Yeri Lee; Kyeung Min Joo; Jeongwu Lee; Do-Hyun Nam
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

10.  SLUG silencing increases radiosensitivity of melanoma cells in vitro.

Authors:  Chiara Arienti; Anna Tesei; Silvia Carloni; Paola Ulivi; Antonino Romeo; Giulia Ghigi; Enrico Menghi; Anna Sarnelli; Elisabetta Parisi; Rosella Silvestrini; Wainer Zoli
Journal:  Cell Oncol (Dordr)       Date:  2012-12-19       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.